Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mio Ueda"'
Autor:
Ko Hanai, Makoto Akamatsu, Aki Fujimori, Harumichi Higashi, Yumiko Horie, Yoshiaki Itaya, Minoru Ito, Tomoko Kanamaru, Hiroshi Kawaguchi, Kan Kikuchi, Hideo Kobayashi, Machiko Komatsu, Takao Kubota, Kenichi Kudo, Satoshi Kurihara, Ikuto Masakane, Junichiro Mera, Sonoo Mizuiri, Kimiko Moriyama, Junichiro Nagasawa, Sumiyo Nagata, Yoshihiko Nakagawa, Satoshi Nakazato, Takahiro Nishi, Yoshihiko Noma, Naoyuki Odaguchi, Senji Okuno, Shiwori Osada, Hisashi Ozasa, Sumihiko Sato, Tokihiko Sawada, Tsuyako Shimajiri, Yukiko Shimamoto, Masakazu Suda, Toshihide Suzuki, Hiromichi Suzuki, Maki Takahashi, Hajime Takahashi, Toshimasa Takahashi, Yoshihiro Takebayashi, Masanobu Takeda, Hiroyuki Tamura, Yoshiko Tanaka, Sohei Tokunaka, Shinji Tsuda, Mio Ueda, Ichiro Yamaguchi, Hirohisa Yamamoto, Yasuko Uchigata, Tetsuya Babazono
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-8 (2020)
Abstract Background The association of glycated albumin (GA) with mortality is unclear in chronic hemodialysis patients with diabetes. We investigated the usefulness of GA by comparing it with hemoglobin A1c (HbA1c) in this patient population. Resear
Externí odkaz:
https://doaj.org/article/794e658391d44eae8863869464e49af1
Autor:
Mio Ueda, Minako Akiyama, Shinnichi Iwai, Miho Nagai, Eiichiro Kanda, Yume Nagaoka, Yoshihiko Kanno, Michio Nagaoka, Rie Suzuki, Kakei Ryu, Yoshitaka Miyaoka, Yoshiko Tanaka, Hiroshi Yoshimoto
Publikováno v:
Hemodialysis International. 22:388-393
Introduction: Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50f3d24543183ebe2cdeb34309cc8430
https://doi.org/10.1111/hdi.12620
https://doi.org/10.1111/hdi.12620
Autor:
Senji Okuno, Hideo Kobayashi, Toshimasa Takahashi, Ikuto Masakane, Yoshihiro Takebayashi, Yumiko Horie, Shinji Tsuda, Yukiko Shimamoto, Shiwori Osada, Sumihiko Sato, Mio Ueda, Hiroshi Kawaguchi, Naoyuki Odaguchi, Sumiyo Nagata, Yoshiaki Itaya, Sonoo Mizuiri, Satoshi Kurihara, Hajime Takahashi, Tsuyako Shimajiri, Hisashi Ozasa, Yoshihiko Noma, Harumichi Higashi, Yasuko Uchigata, Tomoko Kanamaru, Ko Hanai, Takao Kubota, Yoshiko Tanaka, Junichiro Mera, Machiko Komatsu, Junichiro Nagasawa, Aki Fujimori, Yoshihiko Nakagawa, Hirohisa Yamamoto, Kenichi Kudo, Hiroyuki Tamura, Satoshi Nakazato, Kimiko Moriyama, Masanobu Takeda, Masakazu Suda, Toshihide Suzuki, Takahiro Nishi, Makoto Akamatsu, Kan Kikuchi, Ichiro Yamaguchi, Hiromichi Suzuki, Minoru Ito, Tetsuya Babazono, Sohei Tokunaka, Maki Takahashi, Tokihiko Sawada
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-8 (2020)
Background The association of glycated albumin (GA) with mortality is unclear in chronic hemodialysis patients with diabetes. We investigated the usefulness of GA by comparing it with hemoglobin A1c (HbA1c) in this patient population. Research design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7bc8e3971bf608b10a6088ee5eb68b7
http://hdl.handle.net/10470/00033006
http://hdl.handle.net/10470/00033006
Autor:
Yukiko Shimamoto, Sayaka Takahashi, Yoshiko Tanaka, Mari Takano, Keiko Suzuki, Kosaku Nitta, Mio Ueda
Publikováno v:
International Journal of Clinical Medicine. :652-660
Background: New erythropoiesis-stimulating agents (ESAs) with a longer half-life have been developed for the treatment of anemia as a complication of patients with end-stage renal disease. Objectives: The objective of the present study was to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e949226eb9f84f5b839ccedf94752a9
https://doi.org/10.4236/ijcm.2015.69087
https://doi.org/10.4236/ijcm.2015.69087
Autor:
Yume, Nagaoka, Yoshiko, Tanaka, Hiroshi, Yoshimoto, Rie, Suzuki, Kakei, Ryu, Mio, Ueda, Minako, Akiyama, Miho, Nagai, Yoshitaka, Miyaoka, Eiichiro, Kanda, Shinnichi, Iwai, Michio, Nagaoka, Yoshihiko, Kanno
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 22(3)
Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been established in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3a130eacddfd02b2e84617c8b58ad32
https://pubmed.ncbi.nlm.nih.gov/29227568
https://pubmed.ncbi.nlm.nih.gov/29227568
Autor:
Abigail Harris, Mio Ueda
Publikováno v:
The International Handbook of Consultation in Educational Settings ISBN: 9781315795188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d540ae601322dc9b1188d4cee8252606
https://doi.org/10.4324/9781315795188-9
https://doi.org/10.4324/9781315795188-9
Publikováno v:
Renal Replacement Therapy. 2
The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio has been shown to be a predictor of cardiovascular (CV) outcomes in the general population. The aim of this study was to determine whether the TG/HDL-C ratio is a predictor of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747cdf0e24c568ff7fbb8e2c45fd7417
https://doi.org/10.1186/s41100-016-0069-4
https://doi.org/10.1186/s41100-016-0069-4
Publikováno v:
Renal Replacement Therapy. 1
The nutritional status of patients on maintenance hemodialysis (MHD) is a strong predictor of their survival. We assessed the reliability of a protein-energy wasting (PEW) score as a predictor of the survival of Japanese MHD patients. The study subje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ef40110eb32a22d960c6049f13e201
https://doi.org/10.1186/s41100-015-0012-0
https://doi.org/10.1186/s41100-015-0012-0
Autor:
Taeko Kakinuma, Fumiko Kojima, Motofumi Suzuki, Yoshiko Tanaka, Kosaku Nitta, Takashi Akiba, Mio Ueda, Hiroaki Haruguchi
Publikováno v:
Nihon Toseki Igakkai Zasshi. 42:387-391
症例は65歳女性．1983年血液透析導入（原疾患不明）．1991年生体腎移植．2001年血液透析再導入．2007年7月右前腕内シャント閉塞にて左前腕人工血管（グラシル®）移植術施行．手術時出血
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd64f86fcc7d1ca28559a42524407476
https://doi.org/10.4009/jsdt.42.387
https://doi.org/10.4009/jsdt.42.387
Autor:
Mio Ueda, Masaki Takahashi, Misao Tsukada, Keiko Uchida, Yasuko Yabuki, Wako Yumura, Takashi Akiba, Takumi Yoshida, Shunji Shiohira, Masae Iwamoto, Jun Ino, Kosaku Nitta
Publikováno v:
Nihon Toseki Igakkai Zasshi. 39:1481-1485
症例は46歳の女性. 29歳出産時に子宮内膜症を指摘された既往がある. 2000年7月原因不明の腎不全に対し透析導入された. 2001年10月より月経時痛が増強し, 2002年4月より月経前後に右自然気胸
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36a46341c99b1377dedda5a9e0e3b0d1
https://doi.org/10.4009/jsdt.39.1481
https://doi.org/10.4009/jsdt.39.1481